One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous ThromboembolismThe Kids-DOTT Randomized Clinical Trial
Neil A. Goldenberg, MD, PhD; John M. Kittelson, PhD; Thomas C. Abshire, MD; et al.
doi : 10.1001/jama.2021.23182
Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without DiabetesThe STEP 8 Randomized Clinical Trial
Domenica M. Rubino, MD; Frank L. Greenway, MD; Usman Khalid, MD, PhD; et al.
doi : 10.1001/jama.2021.23619
Discriminative Accuracy of Chronic Obstructive Pulmonary Disease Screening Instruments in 3 Low- and Middle-Income Country Settings
Trishul Siddharthan, MD; Suzanne L. Pollard, PhD, MSPH; Shumonta A. Quaderi, MBBS, BSc; et al.
doi : 10.1001/jama.2021.23065
US State-Level Legal Interventions Related to COVID-19 Vaccine Mandates
Breanna Fernandes; Mark Christopher Navin, PhD; Dorit Rubinstein Reiss, PhD; et al.
doi : 10.1001/jama.2021.22122
Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection
Timothy A. Bates, BSc; Savannah K. McBride, BSc; Bradie Winders, CNA; et al.
doi : 10.1001/jama.2021.22898
Achieving Diagnostic Excellence for Sepsis
Derek C. Angus, MD, MPH; Andrew B. Bindman, MD
doi : 10.1001/jama.2021.23916
One Year of COVID-19 VaccinesA Shot of Hope, a Dose of Reality
Amanda C. Cohn, MD; Barbara E. Mahon, MD, MPH; Rochelle P. Walensky, MD, MPH
doi : 10.1001/jama.2021.23962
New State Consumer Protections Against Medical Debt
Christopher T. Robertson, JD, PhD; Mark Rukavina, MBA; Erin C. Fuse Brown, JD, MPH
doi : 10.1001/jama.2021.23061
Duration of Anticoagulant Treatment for Acute Provoked Venous Thromboembolism in Pediatric Patients
Benoît Mâsse, PhD; Nancy Robitaille, MD; Jacques Lacroix, MD
doi : 10.1001/jama.2021.21890
Screening for Chronic Obstructive Pulmonary DiseaseUnmet Needs and Future Considerations
Barbara P. Yawn, MD, MSc; Nancy K. Leidy, PhD; Fernando Martinez, MD, MS
doi : 10.1001/jama.2021.23255
Diagnosis and Treatment of Sexually Transmitted InfectionsA Review
Susan Tuddenham, MD, MPH; Matthew M. Hamill, MBChB, PhD; Khalil G. Ghanem, MD, PhD
doi : 10.1001/jama.2021.23487
Using Cardinality Matching to Design Balanced and Representative Samples for Observational Studies
Bijan A. Niknam, BS; Jose R. Zubizarreta, PhD
doi : 10.1001/jama.2021.20555
Axillary Lymphadenopathy After COVID-19 Vaccination in a Woman With Breast Cancer
Diana L. Lam, MD; Meghan R. Flanagan, MD, MPH
doi : 10.1001/jama.2021.20010
PrEP Awareness Is Low Among Heterosexual People
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2021.23743
Younger Adults With Diabetes Miss Care, Disregard COVID-19 Precautions
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2021.23011
COVID-19 Vaccine Focused on T-Cell Response Promising in Early Trial
Jennifer Abbasi
doi : 10.1001/jama.2021.24118
What Is Cystic Fibrosis?
Tori M. Endres, MD; Michael W. Konstan, MD
doi : 10.1001/jama.2021.23280
Effect of Lactobacillus rhamnosus GG on Incident Pneumonia in Critically Ill Patients
Cheng-Yi Wang, MD; Chao-Hsien Chen, MD; Chih-Cheng Lai, MD
doi : 10.1001/jama.2021.21216
Effect of Lactobacillus rhamnosus GG on Incident Pneumonia in Critically Ill Patients—Reply
Jennie Johnstone, MD, PhD; Diane Heels-Ansdell, MSc; Deborah Cook, MD, MSc
doi : 10.1001/jama.2021.21219
Saliva RT-PCR Sensitivity Over the Course of SARS-CoV-2 Infection
Anne L. Wyllie, PhD; Prem K. Premsrirut, MD, PhD
doi : 10.1001/jama.2021.21703
Saliva RT-PCR Sensitivity Over the Course of SARS-COV-2 Infection—Reply
Pia S. Pannaraj, MD, MPH; Zion Congrave-Wilson, MS; Yesun Lee, PhD
doi : 10.1001/jama.2021.21706
A Pulmonary Embolism Diagnostic Strategy in Patients Hospitalized for COPD Exacerbation
Wei Xiong, MD, PhD; Xuejun Guo, MD, PhD
doi : 10.1001/jama.2021.21709
A Pulmonary Embolism Diagnostic Strategy in Patients Hospitalized for COPD Exacerbation—Reply
David Jiménez, MD, PhD; Alvar AgustÃ, MD, PhD; Behnood Bikdeli, MD, MS
doi : 10.1001/jama.2021.21712
